Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2023-02-09 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
独立董事关于董事会聘任高级管理人员的意见
Board/Management Information Classification · 100% confidence The document is a statement from independent directors regarding the appointment of senior management personnel at the company. It references compliance with company law and internal regulations, and it provides opinions on the qualifications and appointment procedures of senior management. There is no financial data, no mention of financial results, no regulatory filings or voting results, and no indication of a report publication or announcement. The content clearly relates to management information, specifically the appointment of senior management. Therefore, the document fits best under the category 'Board/Management Information (MANG)'. The document length is short but contains substantive content about management appointments, not just an announcement or certification.
2023-02-09 Chinese
关于2023年1月份生猪销售简报
Regulatory Filings Classification · 95% confidence The document is a sales brief for January 2023, detailing the company's sales volume and revenue for live pigs, with explanations for changes and risk warnings. It is a short announcement (881 characters) providing interim sales data but does not contain comprehensive financial statements or detailed financial analysis. It is not a full interim or quarterly report (IR) because it lacks substantive financial data and analysis. It is also not an earnings release (ER) since it focuses on sales volume and revenue for a specific product segment rather than overall quarterly financial results. The document serves as a brief operational update on sales performance, which fits best under the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-02-09 Chinese
第八届监事会第一次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first (extraordinary) meeting of the eighth Supervisory Board of Tian Kang Bio Co., Ltd. It includes details about the election of a new chairman of the Supervisory Board and confirms the legality and attendance of the meeting. There are no financial statements, audit results, or detailed financial data presented. The document is a formal announcement of a board/management change, specifically related to the Supervisory Board leadership. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a certification, so it is not a Regulatory Filing or Report Publication Announcement.
2023-02-09 Chinese
第八届董事会第一次(临时）会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the first (extraordinary) meeting of the eighth board of directors of Tian Kang Biological Co., Ltd. It details the election and appointment of the chairman, board committees, general manager, senior management, board secretary, audit director, and securities affairs representative. It includes voting results and biographical information of the appointed individuals. There is no financial data, earnings information, or report content. The document is clearly about changes in the company's board and senior management positions. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 5,081 characters, which is consistent with a detailed management announcement rather than a brief notice or report publication announcement.
2023-02-09 Chinese
2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 first extraordinary general meeting of shareholders of Tian Kang Biological Co., Ltd. It includes voting results for various board and supervisory committee elections, legal opinions on the meeting's validity, and procedural details. There is no financial data or report content, but rather the official voting results and decisions made at the meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is about 4109 characters, which is sufficient for a full voting results announcement, not just a brief notice. Therefore, the correct classification is DVA with high confidence.
2023-02-03 Chinese
关于天康生物股份有限公司2023年第一次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2023 first extraordinary general meeting (临时股东大会) of Tian Kang Bio. It details the legality of the meeting's call, attendance qualifications, voting procedures, and the election of board members and supervisors. The document is not the meeting materials or presentation itself, nor is it a simple announcement of the meeting or voting results. Instead, it is a legal opinion on the meeting's conduct and results. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA), as it includes official voting results and legal validation of the meeting's resolutions. The document length (4776 characters) and content confirm it is a substantive legal opinion on voting results, not a brief announcement or proxy solicitation. Therefore, the appropriate classification is DVA with high confidence.
2023-02-03 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.